Gline Matthew sold ROIV
December 15, 2025 · Form 4 insider transaction
Gline Matthew sold 3,739 shares of Roivant Sciences Ltd. at $21.68 per share, a transaction worth $81.1K. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.; All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.